These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1815 related items for PubMed ID: 17472822
1. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH, Burgess ED, Assouline L, Vanjaka A. Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [Abstract] [Full Text] [Related]
2. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age]. Gosse P, Vaur L, Dutrey-Dupagne C, Genes N, Destrée D, Elkik F. Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662 [Abstract] [Full Text] [Related]
3. Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension in Canada. Tytus RH, Burgess ED, Assouline L, Vanjaka A. Curr Med Res Opin; 2009 Jun; 25(6):1379-84. PubMed ID: 19422278 [Abstract] [Full Text] [Related]
4. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil]. Widimský J, Dzúrik R. Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054 [Abstract] [Full Text] [Related]
5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL. Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [Abstract] [Full Text] [Related]
6. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [Abstract] [Full Text] [Related]
7. Blood pressure control rates with an antihypertensive regimen including trandolapril in a Canadian usual-care setting. Tytus RH, Assouline L, Vanjaka A. Adv Ther; 2011 Sep; 28(9):789-98. PubMed ID: 21850512 [Abstract] [Full Text] [Related]
8. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I. Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [Abstract] [Full Text] [Related]
9. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators. Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [Abstract] [Full Text] [Related]
10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
11. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS. Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099 [Abstract] [Full Text] [Related]
12. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial. Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R. Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004 [Abstract] [Full Text] [Related]
13. Preventing microalbuminuria in type 2 diabetes. Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G, Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators. N Engl J Med; 2004 Nov 04; 351(19):1941-51. PubMed ID: 15516697 [Abstract] [Full Text] [Related]
14. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy. Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG. Int J Clin Pharmacol Ther; 1998 Aug 04; 36(8):425-31. PubMed ID: 9726695 [Abstract] [Full Text] [Related]
15. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F. Clin Ther; 2004 Sep 04; 26(9):1436-45. PubMed ID: 15531006 [Abstract] [Full Text] [Related]
16. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension. Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR. Ann Pharmacother; 2008 Apr 04; 42(4):498-504. PubMed ID: 18364402 [Abstract] [Full Text] [Related]
17. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study]. Fan CM, Yan LR, Tao YK, Wang L, Li YQ, Gao MM, Wang YN, Li CX, Wang XW, Lu XL, Pang HM, Li YS. Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan 04; 39(1):57-60. PubMed ID: 21418799 [Abstract] [Full Text] [Related]
19. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH). Palma Gámiz JL, Pêgo M, Contreras EM, Anglada MP, Martínez JO, Esquerra EA, Sagastagoitia Gorostiza JD, Iberian Multicenter Imidapril Study on Hypertension. Clin Ther; 2006 Dec 04; 28(12):2040-51. PubMed ID: 17296460 [Abstract] [Full Text] [Related]